Beranda › Kanker Ovarium › Kentucky
Uji klinis Kanker Ovarium di Kentucky
25 studi untuk Kanker Ovarium mencari peserta di lokasi di Kentucky.
Kota di Kentucky
Teks studi resmi (Bahasa Inggris)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05564377A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0251 - Norton Cancer Institute, Louisville
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 29 Sep 2026 · NCT05128825A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Baptist Health Lexington /ID# 275218, Lexington
- Norton Cancer Institute - St. Matthews /ID# 276173, Louisville
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 29 Sep 2026 · NCT06890338A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Baptist Health Lexington /ID# 278267, Lexington
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 22 Sep 2026 · NCT07059845A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Baptist Health Lexington, Lexington
- Norton Women's and Children's Hospital, Louisville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213804Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Norton Cancer Institute, Louisville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Norton Cancer Institute, Louisville
Menerima pesertaFase 2
Usia 18 hingga 99 · Wanita · Diperbarui 15 Sep 2026 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- St Elizabeth Healthcare, Edgewood
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 15 Sep 2026 · NCT07214779FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Norton Cancer Institute Research, Louisville
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06303505Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Norton Cancer Institute, St. Matthews Clinic, Louisville
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 14 Sep 2026 · NCT06787612A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- St. Elizabeth Healthcare, Edgewood
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06774963Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- University of Kentucky/Markey Cancer Center, Lexington
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07001748A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Baptist Health Corbin, Corbin
- Baptist Health Lexington, Lexington
- Norton Hospital Pavilion and Medical Campus, Louisville
- dan 5 lainnya
Menerima peserta
Usia 35 hingga 50 · Wanita · Diperbarui 7 Agu 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Baptist Health Corbin, Corbin
- Commonwealth Cancer Center-Corbin, Corbin
- dan 10 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- St. Elizabeth Medical Center, Edgewood
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06161025Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kentucky, Lexington
Menerima pesertaFase 1/2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756EXoPERT EMERALD Clinical Study
- Lexington VA Healthcare System, Lexington
- KCTL, Louisville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT07186296A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
- St. Elizabeth Medical Center - Edgewood /ID# 272113, Edgewood
- Baptist Health Lexington /ID# 272211, Lexington
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 26 Mei 2026 · NCT06682988Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of Kentucky Medical Center, Lexington
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 16 Apr 2026 · NCT05659381Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
- University of Kentucky, Lexington
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Apr 2026 · NCT04779554Combination Therapy for Recurrent Ovarian Cancer
- UofL Health Brown Cancer Center, Louisville
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 19 Mar 2026 · NCT05610735A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Kentucky Markey Cancer Center, Lexington
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863First in Human Study of TORL-1-23 in Participants With Advanced Cancer
- University of Kentucky Medical Center, Lexington
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT05103683cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- Markey Cancer Center, Lexington
Menerima pesertaSukarelawan sehat diterima
Usia 24 ke atas · Wanita · Diperbarui 14 Nov 2025 · NCT04473833Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.